Effect of laminin 332 on motility and invasion in bladder cancer

Sung-Gu Kang, Young Ran Ha, Young Hwii Ko, Seok Ho Kang, Kwan Joong Joo, Hyun Yee Cho, Hong Seok Park, Chul Hwan Kim, Soon Young Kwon, Je-Jong Kim, Jun Cheon, Jeong Gu Lee

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We examined the correlation between laminin 332 and malignancy in bladder cancer patients, and, using a strain of invasive bladder cancer cells, determined whether laminin 332 causes bladder cancer motility and invasion. To investigate the correlation between laminin 332 g2 distribution and patient outcome, we performed a semiquantitative immunohistochemical analysis of 35 paraffin-embedded samples using the antibody D4B5, which is specific for the laminin 5 γ2 chain. To evaluate the role of laminin 332 in NBT-II cell motility and invasion, we used a scratch assay and the Boyden chamber chemoinvasion system. Tumor stage and grade were significantly correlated with a loss of laminin 332 γ2 chain from the basement membrane (p = 0.001) and its retention in the cytoplasm (p = 0.001) (Kruskal-Wallis test). Kaplan-Meier survival curves revealed an association between the risk of progression and cytoplasmic retention of the laminin 332 γ2 chain. In addition, an in vitro scratch assay showed an increase in the migration of cells treated with laminin 332 from their cluster. The Boyden chamber assay showed that laminin 332 potentiated NBT-II cell invasion. Immunohistochemistry results showed that bladder cancer patients with a higher malignancy expressed more laminin 332. The in vitro scratch and invasion assay showed that laminin 332 stimulated the motility and invasion of bladder cancer cells. The invasion assay explains the correlation between laminin 332 expression and bladder cancer malignancy.

Original languageEnglish
Pages (from-to)422-429
Number of pages8
JournalKaohsiung Journal of Medical Sciences
Volume29
Issue number8
DOIs
Publication statusPublished - 2013 Aug 1

    Fingerprint

Keywords

  • Invasion
  • Laminin 332
  • Prognosis
  • Urothelial cell carcinoma

ASJC Scopus subject areas

  • Medicine(all)

Cite this